Treatment of upper airway allergic responses
US5869479A · kind A · utility
58Cited by
5References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 14, 1997 |
| Grant date | Feb 9, 1999 |
| Priority date | — |
| Expiry date | Aug 14, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/445
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Relief from the symptoms of rhinitis is obtained by treatment with: (a) an antihistaminic effective amount of a histamine H.sub.1 receptor antagonist; together with (b) a sufficient amount of a histamine H.sub.3 receptor antagonist to provide a nasal decongestant effect. The components may be administered together in a single dosage form, or separately in the same or different dosage forms to maintain therapeutic systemic levels of both components.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.